Document is current
Any future updates will be listed below
-
Authors
Short, Emma https://orcid.org/0000-0001-5050-589X
,
Adcock, Ian M.
Al-Sarireh, Bilal
Ager, Ann
Ajjan, Ramzi
Akbar, Naveed
Akeroyd, Michael A.
Alsaleh, Ghada
Al-Sharbatee, Ghada
Alavian, Kambiz
Amoaku, Winfried
Andersen, Julie
Antoniades, Chrystalina
Arends, Mark J.
Astley, Sue
Atan, Denize
Attanoos, Richard
Attems, Johannes
Bain, Steve
Balaskas, Konstantinos
Balmus, Gabriel
Bance, Manohar
Barber, Thomas M.
Bardhan, Ajoy
Barker, Karen
Barnes, Peter
Basatemur, Gemma
Bateman, Adrian
Bauer, Moises Evandro
Bellamy, Christopher
van Beek, Edwin
Bellantuono, Ilaria
Benbow, Emyr
Bhandari, Sunil
Bhatnagar, Rahul
Bloom, Philip
Bowdish, Dawn
Bowerman, Melissa
Burke, Melanie
Carare, Roxana
Carrington, Emma Victoria
Castillo-Quan, Jorge Iván
Clegg, Peter
Cole, James
Cota, Carlo
Chazot, Paul
Chen, Christopher
Cheong, Ying
Christopher, Gary
Church, George
Clancy, David
Cool, Paul
Galdo, Del
Dalakoti, Mayank
Dasgupta, Soumit
Deane, Colleen
Dhasmana, Devesh
Dojcinov, Stefan
Di Prete, Monia
Du, Huaidong
Duggal, Niharika A.
Ellmers, Toby
Emanueli, Costanza
Emberton, Mark
Erusalimsky, Jorge D.
Feldmeyer, Laurence
Fleming, Alexander
Forbes, Karen
Foster, Thomas C.
Frasca, Daniela
Frayling, Ian
Freedman, Daniel
Fülöp, Tamas
Ellison-Hughes, Georgina
Gazzard, Gus
George, Christopher
Gil, Jesus
Glassock, Richard
Goldin, Rob
Green, John
Guymer, Robyn
Haboubi, Hasan
Harries, Lorna
Hart, Simon
Hartley, Douglas
Hasaballa, Sebri
Henein, Christin
Helliwell, Maggie
Henderson, Emily
Heer, Rakesh
Holte, Kristofer
Idris, Iskander
Isenburg, David
Jylhävä, Juulia
Iqbal, Ahmed
Jones, Simon W.
Kalaria, Rajesh
Kanamarlapudi, Venkateswarlu
Kempf, Werner
Kermack, Alexandra J.
Kerns, Jemma
Koulman, Albert
Khan, Adnan H.
Kinross, James
Klaucane, Katarina
Krishna, Yamini
Gill, Harinderjit Singh
Lakatta, Edward
Laconi, Ezio
Lazar, Alpar
Leeuwenburgh, Christiaan
Leung, Samantha
Li, Xuan
van der Linde, Ian
Lopes, Luísa V.
Lorenzini, Antonello
Lotery, Andrew
Machado, Pedro
Mackie, Sarah
Madeddu, Paolo
Maier, Andrea
Mukkanna, Krishna
Manousou, Pinelopi
Markey, Oonagh
Mauro, Claudio
McDonnell, Barry
Medina, Reinhold J.
Meran, Soma
Metzler-Baddeley, Claudia
Meglinksi, Ignor
Milman, Neta
Mitteldorf, Christina
Montgomery, Ruth
Morris, Andrew Conway
Mühleisen, Beda
Mukherkee, Abhik
Murray, Andrew
Nelson, Scott
Nicolaou, Anna
Nirenberg, Alexander
Noble, Simon
Nolan, Lisa S.
Nus, Meritxell
Van On, Canh
Osei-Lah, Victor
Peffers, Mandy
Palmer, Antony
Palmer, Donald
Palmer, Laura
Parry-Smith, William
Pawelec, Graham
Peleg, Shahaf
Perera, Ranmith
Pitsillides, Andrew
Plack, Christopher J.
Progatzsky, Franze
Pyott, Sonja
Rajput, Kaukab
Rashid, Sameera
Ratnayaka, J. Arjuna
Ratnayake, Sudhira A. B.
Rodriguez-Justo, Manuel
Rosa, Arianna Carolina
Rule, Andrew
Sanger, Gareth J.
Sayers, Ian
Saykin, Andrew
Selvarajah, Dinesh
Sethi, Jaswinder
Shanahan, Cathy
Shen-Orr, Shai
Sheridan, Carl
Shiels, Paul
Sidlauskas, Kastytis
Sivaprasad, Sobha
Sluimer, Judith
Small, Gary
Smith, Peter
Smith, Rebecca
Snelling, Sarah
Spyridopoulos, Ioakim
Raghavan, Ramasamy Srinivasa
Steel, David
Steel, Karen P.
Stewart, Claire
Stone, Keeron
Subbarayan, Selvarani
Sussman, Mark
Svensson, Jonas
Tadanki, Vyshnavi
Tan, Ai Lyn
Tanzi, Rudolph E.
Tatler, Amanda
Tavares, Adriana A. S.
Mohd, Tengku Amatullah Madeehah Tengku
Tiganescu, Ana
Timmons, James
Tree, Jeremy
Trivedi, Drupad
Tsochatzis, Emmanuel A.
Tsimpida, Dialechti
Vinke, Elisabeth J.
Whittaker, Anna
Vallabh, Neeru A.
Veighey, Kristin
Venables, Zoe C.
Venkat, Reddy
Vernooij, Meike W.
Verschoor, Chris
Vinciguerra, Manlio
Vukanovic, Vesna
Vyazovskiy, Vladyslav
Walker, James
Wakefield, Richard
Watkins, Adam J.
Webster, Anthony
Weight, Caroline
Weinberger, Birgit
Whitney, Susan L.
Willis, Rosalind
Witkowski, Jacek M.
Yeo, Leonard L. L.
Chung, Tham Yhi
Yu, Emma
Zemel, Michael
Calimport, Stuart https://orcid.org/0000-0002-0085-0385
Bentley, Barry https://orcid.org/0000-0002-4360-5902
-
Funding
Funding for this research was provided by:
Norn Group (Impetus Longevity Grant, Norn Group)
- License Information
-
More Information
Article History
Received: 21 June 2024
Accepted: 9 August 2024
First Online: 21 September 2024
Declarations
:
: ACM sits on the scientific advisory board of Cambridge Infection Diagnostics and has received speaking fees from Biomerieux, Fischer and Paykel, Thermo Fisher and Boston Scientific. AAST declares submission of two patent applications (PCT/EP2019/066546 and PG450503GB/YR), one of which is currently being explored with Life Molecular Imaging. AAST has an active collaboration with Unilever. AAST is a recipient of a Wellcome Trust Technology Development Award (221295/Z/20/Z) focused on understanding synaptic changes over the course of a lifespan; and a CZI grant DAF2021-225273 and grant from the Chan Zuckerberg Initiative DAF, an advised fund of Silicon Valley Community Foundation (funder ). AL has received financial support from Amgen, Apellis, Bayer, Boehringer Ingelheim, Eyebiotech, Outlook Therapeutics, Kriya and Roche. AN has received research grants from the BBSRC, BHF, Boots plc, SkinBioTherapeutics, Unilever, AstraZeneca and Waters, and provided consultancy for Intercos. AS receives support from multiple NIH grants (P30 AG010133, P30 AG072976, R01 AG019771, R01 AG057739, U19 AG024904, R01 LM013463, R01 AG068193, T32 AG071444, U01 AG068057, U01 AG072177 and U19 AG074879). He has also received support from Avid Radiopharmaceuticals, a subsidiary of Eli Lilly (in kind contribution of PET tracer precursor) and participated in Scientific Advisory Boards (Bayer Oncology, Eisai, Novo Nordisk and Siemens Medical Solutions USA, Inc) and an Observational Study Monitoring Board (MESA, NIH NHLBI), as well as External Advisory Committees for multiple NIA grants. He also serves as Editor-in-Chief of Brain Imaging and Behavior, a Springer-Nature Journal. BLB sits on the scientific advisory board of Five Alarm Bio Ltd. Cambridge, UK. EJRVB is advisory board member of DeepHealth, a member of the steering committee of an Astra Zeneca sponsored study (PINPOINT) and owner of QCTIS Ltd (a Radiology consulting company). GB is the founder, director and CEO of Function RX Ltd. GP has acted as a consultant for Novartis, Roche, Pfizer, GlaxoSmithKline, Immatics and Astellas. He is a member of the Scientific Advisory Boards of Repair Biotechnologies, Inc., ImmuneAGE Bio, Inc., MoglingBio, Inc., SENS Foundation, Alpine Institute of Zurich, XPRIZE Health span. He owns equity in ImmuneAGE Bio, Inc. HSG (Harinderjit Singh Gill) has acted as a consultant for Smith & Nephew and Invibio. JG has acted as a consultant for Unity Biotechnology, Geras Bio, Myricx Pharma and Merck KGaA. Pfizer and Unity Biotechnology have funded research in JG’s lab (unrelated to the work presented here). JG owns equity in Geras Bio. JG is a named inventor in MRC and Imperial College patents, both related to senolytic therapies. LH is the founder, director and CSO of SENISCA Ltd. PB has received research funding and/or one-off payments for advisory boards and/or speaker honoraria from: Iridex, Glaukos & BVI (EndoOptiks). PMM has received consulting/speaker’s fees from Abbvie, BMS, Celgene, Eli Lilly, Galapagos, Janssen, MSD, Novartis, Orphazyme, Pfizer, Roche and UCB, all unrelated to this manuscript, and is supported by the National Institute for Health Research (NIHR), University College London Hospitals (UCLH) and Biomedical Research Centre (BRC). RAA reports institutional research grants, honoraria, education support or consulting fees from Abbott Diabetes Care, AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Menarini Pharmaceuticals, Merck Sharp & Dohme and Novo Nordisk. RG sits on advisory boards of Roche, Genentech, Belite Bio, AbbVie, Apellis, Astellas, Bayer, Boehringer Ingelheim, Janssen Pharmaceuticals, Ocular Therapeutix, Complement therapeutics, Character Bioscience. SLM has provided consultancy on behalf of her institution for Roche/Chugai, Sanofi, AbbVie, AstraZeneca, Pfizer; investigator on clinical trials for Sanofi, GSK, Sparrow; speaking/lecturing on behalf of her institution for Roche/Chugai, Vifor, Pfizer, UCB, Novartis, Fresenius Kabi and AbbVie; chief investigator on STERLING-PMR trial, funded by NIHR; patron of the charity PMRGCAuk. No personal remuneration was received for any of the above activities. Support from Roche/Chugai to attend EULAR2019 in person and from Pfizer to attend ACR Convergence 2021 virtually. SLM is supported in part by the NIHR Leeds Biomedical Research Centre (NIHR203331). The views expressed in this article are those of the authors and not necessarily those of the NIHR, the NIHR Leeds Biomedical Research Centre, the National Health Service or the UK Department of Health and Social Care. SS (Sobha Sivaprasad) has received financial support from AbbVie, Amgen, Apellis, Astellas, Bayer, Biogen, Boehringer Ingelheim, Eyebiotech, Eyepoint Phamaceuticals, Iveric Bio, Janssen Pharmaceuticals, Nova Nordisk, Optos, Ocular Therapeutix, Kriya Therapeutics, OcuTerra, Roche, Stealth Biotherapeutics and Sanofi. SSO holds is a consultant and holds equity in CytoReason. WA Consultancies/Advisory Board Memberships: Abbvie, Allergan, Alimera, Bayer, Novartis, Roche. Educational travel grants from Abbvie, Allergan, Alimera, Bayer, Novartis, Roche. Research grants from Allergan, Boerhinger Ingelheim, Bayer.
